Biomotorai - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 6,492,713 | 10,173,556 | 14,582,404 | 22,461,762 | 24,934,168 | 22,855,786 | 12,652,720 | 13,794,014 |
| Profit before tax | 296,081 | 444,571 | 839,331 | 1,766,619 | 2,338,823 | 1,753,252 | 506,218 | 370,938 |
| Net profit | 260,963 | 388,611 | 743,988 | 1,569,853 | 1,984,394 | 1,499,595 | 465,758 | 342,741 |
| Equity | 768,174 | 1,136,785 | 1,833,805 | 3,310,516 | 5,000,792 | 5,559,211 | 5,461,390 | 4,254,607 |
| Liabilities | 232,775 | 322,591 | 660,429 | 1,531,113 | 1,352,239 | 1,154,479 | 1,239,533 | 909,685 |
| Non-current assets | 198,978 | 234,579 | 503,923 | 842,915 | 841,301 | 855,588 | 1,622,053 | 1,608,218 |
| Current assets | 801,971 | 1,224,797 | 2,165,812 | 4,175,165 | 5,629,754 | 5,947,805 | 5,124,825 | 3,556,315 |
| Total assets | 1,000,949 | 1,459,376 | 2,669,735 | 5,018,080 | 6,471,055 | 6,803,393 | 6,746,878 | 5,164,533 |
|
Taxes paid
|
||||||||
| Social insurance contributions | - | - | - | - | - | 158,603 | 220,023 | 246,374 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +23.9% | +56.7% | +43.3% | +54.0% | +11.0% | -8.3% | -44.6% | +9.0% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 26.1% | 26.6% | 27.9% | 31.3% | 30.7% | 22.0% | 6.9% | 6.6% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 34.0% | 34.2% | 40.6% | 47.4% | 39.7% | 27.0% | 8.5% | 8.1% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 4.0% | 3.8% | 5.1% | 7.0% | 8.0% | 6.6% | 3.7% | 2.5% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 4.6% | 4.4% | 5.8% | 7.9% | 9.4% | 7.7% | 4.0% | 2.7% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.3 | 0.3 | 0.4 | 0.5 | 0.3 | 0.2 | 0.2 | 0.2 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 608,690 | 939,100 | 1,080,178 | 1,302,131 | 1,347,793 | 1,079,799 | 499,450 | 528,845 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Biomotorai - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2022-12-16 | 2022-12-18 | 7823.69 |
| 2022-01-31 | 2022-02-21 | 3.96 |
| 2021-12-16 | 2021-12-19 | 5975.07 |
Biomotorai - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Biomotorai, UAB (code 300624294) is a private limited liability company engaged in materials recovery. In the 2025 financial year, revenue reached €13.79M, increasing by 9.0% year on year from €12.65M in 2024, but remaining well below €22.86M in 2023, which means the two-year change was negative. Net profit was €342.7K in 2025, compared with €465.8K in 2024 and €1.50M in 2023, while the net profit margin narrowed to 2.5% from 3.7% and 6.6% respectively. At year-end 2025, total assets stood at €5.16M, equity at €4.25M and liabilities at €909.7K. The balance sheet indicates a strong equity position, with an equity ratio of 82.4% and debt-to-equity of 0.21. Return on equity was 8.1% and return on assets 6.6%, while asset turnover reached 2.67x. Revenue per employee was €530.5K, and profit per employee was €13.2K, indicating relatively high productivity despite the lower profitability trend.